Browsing Tag
Biopharmaceuticals
13 posts
Johnson & Johnson strikes $1.2bn deal with Numab Therapeutics for atopic dermatitis candidate
In a significant move to enhance its immunology offerings, Johnson & Johnson (NYSE: JNJ) has announced a definitive…
Biocon Biologics secures license agreement for biosimilar launch in US
In a landmark announcement, Biocon Biologics Ltd (BBL), a fully integrated global biosimilars company and a subsidiary of…
Wockhardt UK and Serum Life Sciences UK join forces to deliver 150 million vaccine doses annually from new fill-finish facility
Find out how Wockhardt and Serum Life Sciences UK are reshaping global vaccine supply with a new high-capacity facility—read more now.